Ramaen Odile, Leulliot Nicolas, Sizun Christina, Ulryck Nathalie, Pamlard Olivier, Lallemand Jean-Yves, Tilbeurgh Herman van, Jacquet Eric
Institut de Chimie des Substances Naturelles, UPR 2301, Centre National de la Recherche Scientifique, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France.
J Mol Biol. 2006 Jun 16;359(4):940-9. doi: 10.1016/j.jmb.2006.04.005. Epub 2006 May 2.
Human multidrug resistance protein 1 (MRP1) is a membrane protein that belongs to the ATP-binding cassette (ABC) superfamily of transport proteins. MRP1 contributes to chemotherapy failure by exporting a wide range of anti-cancer drugs when over expressed in the plasma membrane of cells. Here, we report the first high-resolution crystal structure of human MRP1-NBD1. Drug efflux requires energy resulting from hydrolysis of ATP by nucleotide binding domains (NBDs). Contrary to the prokaryotic NBDs, the extremely low intrinsic ATPase activity of isolated MRP1-NBDs allowed us to obtain the structure of wild-type NBD1 in complex with Mg2+/ATP. The structure shows that MRP1-NBD1 adopts a canonical fold, but reveals an unexpected non-productive conformation of the catalytic site, providing an explanation for the low intrinsic ATPase activity of NBD1 and new hypotheses on the cooperativity of ATPase activity between NBD1 and NBD2 upon heterodimer formation.
人类多药耐药蛋白1(MRP1)是一种膜蛋白,属于ATP结合盒(ABC)转运蛋白超家族。当在细胞膜中过度表达时,MRP1通过输出多种抗癌药物导致化疗失败。在此,我们报道了人类MRP1-NBD1的首个高分辨率晶体结构。药物外排需要核苷酸结合结构域(NBDs)水解ATP产生的能量。与原核生物的NBDs不同,分离的MRP1-NBDs极低的内在ATP酶活性使我们能够获得与Mg2+/ATP结合的野生型NBD1的结构。该结构表明MRP1-NBD1采用了典型的折叠方式,但揭示了催化位点意外的非生产性构象,为NBD1的低内在ATP酶活性提供了解释,并为异二聚体形成时NBD1和NBD2之间ATP酶活性的协同作用提出了新的假说。